DK3277683T3 - Tricyklisk sammensmeltet afledt af 1-(cyklo)alkyl pyridin-2-one nyttig til behandling af kræft - Google Patents

Tricyklisk sammensmeltet afledt af 1-(cyklo)alkyl pyridin-2-one nyttig til behandling af kræft Download PDF

Info

Publication number
DK3277683T3
DK3277683T3 DK16723536.5T DK16723536T DK3277683T3 DK 3277683 T3 DK3277683 T3 DK 3277683T3 DK 16723536 T DK16723536 T DK 16723536T DK 3277683 T3 DK3277683 T3 DK 3277683T3
Authority
DK
Denmark
Prior art keywords
tricyklisk
sammensmeltet
nyttig
kræft
afledt
Prior art date
Application number
DK16723536.5T
Other languages
Danish (da)
English (en)
Inventor
Saravanan Vadivelu
Sridharan Rajagopal
Murugan Chinnapattu
Pavan Kumar Gondrala
Dhanalakshmi Sivanandhan
Chandrika Mulakala
Original Assignee
Jubilant Biosys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jubilant Biosys Ltd filed Critical Jubilant Biosys Ltd
Application granted granted Critical
Publication of DK3277683T3 publication Critical patent/DK3277683T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK16723536.5T 2015-03-30 2016-03-30 Tricyklisk sammensmeltet afledt af 1-(cyklo)alkyl pyridin-2-one nyttig til behandling af kræft DK3277683T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1636CH2015 2015-03-30
PCT/IN2016/050098 WO2016157221A1 (en) 2015-03-30 2016-03-30 Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer

Publications (1)

Publication Number Publication Date
DK3277683T3 true DK3277683T3 (en) 2022-05-02

Family

ID=56015058

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16723536.5T DK3277683T3 (en) 2015-03-30 2016-03-30 Tricyklisk sammensmeltet afledt af 1-(cyklo)alkyl pyridin-2-one nyttig til behandling af kræft

Country Status (16)

Country Link
US (2) US10689390B2 (https=)
EP (1) EP3277683B1 (https=)
JP (1) JP6764877B2 (https=)
KR (1) KR102588109B1 (https=)
CN (1) CN107548393B (https=)
AU (1) AU2016242473B2 (https=)
BR (1) BR112017020739B1 (https=)
CA (1) CA2980266C (https=)
DK (1) DK3277683T3 (https=)
ES (1) ES2911886T3 (https=)
IL (1) IL254528B (https=)
MX (1) MX376112B (https=)
PL (1) PL3277683T3 (https=)
PT (1) PT3277683T (https=)
RU (1) RU2721120C2 (https=)
WO (1) WO2016157221A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT202100277T1 (it) * 2015-09-09 2021-07-12 Jubilant Biosys Ltd Derivati triciclici fusi di piridina-2-0ne e loro uso come inibitori di brd4
CA3045855A1 (en) * 2016-11-10 2018-05-17 Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Nitrogenous macrocyclic compound, preparation method therefor, pharmaceutical composition and application thereof
WO2019214399A1 (zh) * 2018-05-10 2019-11-14 罗欣药业(上海)有限公司 苯并七元杂环类化合物、其制备方法、药物组合物及应用
CN110172068A (zh) * 2019-06-05 2019-08-27 河南龙湖生物技术有限公司 具有抗肿瘤活性的苯并噻唑类化合物及其制备方法和应用
US12527741B2 (en) 2021-06-17 2026-01-20 Wisconsin Alumni Research Foundation Modular dendron micelles for treatment of pulmonary diseases related to fibrosis and viral infection including COVID-19

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1545767A (en) * 1976-06-30 1979-05-16 Aspro Nicholas Ltd Isoquinoline derivatives
WO2008133288A1 (ja) 2007-04-25 2008-11-06 Daiichi Sankyo Company, Limited 三環性アリール化合物
ES2480994T3 (es) 2008-03-31 2014-07-29 Genentech, Inc. Compuestos de tipo benzopirano y benzoxepina inhibidores de PI3K y métodos de uso
US9085582B2 (en) 2010-06-22 2015-07-21 Glaxosmithkline Llc Benzotriazolodiazepine compounds inhibitors of bromodomains
AR084070A1 (es) * 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
CA2901352A1 (en) * 2013-02-19 2014-08-28 Bayer Pharma Aktiengesellschaft Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines
WO2014139324A1 (en) * 2013-03-12 2014-09-18 Abbvie Inc. Tetracyclic bromodomain inhibitors
WO2015018520A1 (en) 2013-08-06 2015-02-12 Oncoethix Sa A bet-brd inhibitor represents a novel agent for alk positive anaplastic large cell lymphoma
US9814728B2 (en) * 2013-09-20 2017-11-14 Saint Louis University Inhibition of DUX4 expression using bromodomain and extra-terminal domain protein inhibitors (BETi)

Also Published As

Publication number Publication date
EP3277683B1 (en) 2022-03-09
JP2018510203A (ja) 2018-04-12
NZ735972A (en) 2024-08-30
KR102588109B1 (ko) 2023-10-12
AU2016242473A1 (en) 2017-10-26
PL3277683T3 (pl) 2022-05-23
CN107548393A (zh) 2018-01-05
US11319326B2 (en) 2022-05-03
RU2017135205A (ru) 2019-04-10
BR112017020739A2 (pt) 2018-07-17
PT3277683T (pt) 2022-06-28
CN107548393B (zh) 2021-03-02
MX376112B (es) 2025-03-07
IL254528B (en) 2020-11-30
EP3277683A1 (en) 2018-02-07
IL254528A0 (en) 2017-11-30
RU2017135205A3 (https=) 2019-07-17
RU2721120C2 (ru) 2020-05-15
BR112017020739B1 (pt) 2023-03-14
US20200331926A1 (en) 2020-10-22
ES2911886T3 (es) 2022-05-23
US20180282345A1 (en) 2018-10-04
CA2980266A1 (en) 2016-10-06
JP6764877B2 (ja) 2020-10-07
US10689390B2 (en) 2020-06-23
AU2016242473B2 (en) 2020-06-25
HK1248686A1 (zh) 2018-10-19
MX2017012387A (es) 2018-06-11
KR20170132278A (ko) 2017-12-01
WO2016157221A1 (en) 2016-10-06
CA2980266C (en) 2025-05-06

Similar Documents

Publication Publication Date Title
DK3334828T3 (en) Fremgangsmåde til at øge replikationen af et cirkulært dna-molekyle
DK3380701T3 (en) Autonom borehulsstrømningsstyringsventil til styring af brøndtryk
DK3827838T5 (en) Hæmning af cytokin-induceret sh2-protein i nk-celler
DK3509582T3 (en) Solvatform af (r)-2-amino-3-phenylpropylcarbamat
DK3386454T3 (en) Forbinding til hudpleje i fugtigt miljø
DK3440128T3 (en) Recirkulation af polymermatrixkompositmateriale
DK3325223T3 (en) Tandhjulspakke til robotarme
DK3137504T5 (en) Antistofbinding til fcrn til behandling af autoimmunsygdomme
GB201400302D0 (en) Telecommunications network
SG11201610220QA (en) Secured network bridge
DK3149048T3 (en) Chloridsalt af tat-nr2b9c
DK3276086T3 (en) Gravitationsfundament til installation af havvindmøller
DK3347540T3 (en) Bærer til et lineært loftspanel
GB201511551D0 (en) Photonics device
DK3359556T3 (en) Modulering af gamma-c-cytokinaktivitet
DK3384915T3 (en) Carrimycin til behandling af mycobacterium tuberculosis-infektioner
GB201514306D0 (en) Network operation
DK3259217T3 (en) Transportsystem til blodprøver
GB201521524D0 (en) Compound
PL3285958T3 (pl) Magazyn
IL258952B (en) A pyranodipyridine compound
DK3277683T3 (en) Tricyklisk sammensmeltet afledt af 1-(cyklo)alkyl pyridin-2-one nyttig til behandling af kræft
DK3723826T3 (en) Anordning til styring af et medicinregime
GB201421170D0 (en) Telecommunications network planning
DK3330264T3 (en) Pyridin substitueret 2-aminopyridin proteinkinase-inhibitorkrystal